Skip to main content

Table 1 Clinical information of 40 glioma samples

From: GNG5 is a novel oncogene associated with cell migration, proliferation, and poor prognosis in glioma

 

Glioma patients N (%)

Group

P value

High GNG5

Low GNG5

Gender

   

0.2049

 Female

21 (52.5%)

13

8

 

 Male

19 (47.5%)

7

12

 

Clinical stage

   

< 0.001*

 WHO II

8 (20%)

0

8

 

 WHO III

10 (25%)

0

10

 

 WHO IV

22 (55%)

20

2

 

Age (years)

47.15 ± 14.49

  

0.5273

 <= 47.15

21 (52.5%)

9

12

 

 > 47.15

19 (47.5%)

11

8

 

Staining of IDH1 R132H

   

0.0309*

 Positive

18 (45%)

5

13

 

 Negative

22 (55%)

14

8

 
  1. High or low is divided by the median value. Chi-square or Fisher's exact test. *P < 0.05 was considered statistically significant
Back to article page

Cancer Cell International

ISSN: 1475-2867

Contact us